Annual EBIT
-$14.02 M
-$3.07 M-28.04%
September 30, 2024
Summary
- As of February 7, 2025, APDN annual earnings before interest & taxes is -$14.02 million, with the most recent change of -$3.07 million (-28.04%) on September 30, 2024.
- During the last 3 years, APDN annual EBIT has fallen by -$1.50 million (-11.96%).
- APDN annual EBIT is now -373.51% below its all-time high of $5.13 million, reached on September 30, 2009.
Performance
APDN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.27 M
+$75.40 K+2.25%
September 1, 2024
Summary
- As of February 7, 2025, APDN quarterly earnings before interest & taxes is -$3.27 million, with the most recent change of +$75.40 thousand (+2.25%) on September 1, 2024.
- Over the past year, APDN quarterly EBIT has increased by +$346.50 thousand (+9.58%).
- APDN quarterly EBIT is now -131.92% below its all-time high of $10.25 million, reached on March 31, 2009.
Performance
APDN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$14.02 M
+$899.50 K+6.03%
September 1, 2024
Summary
- As of February 7, 2025, APDN TTM earnings before interest & taxes is -$14.02 million, with the most recent change of +$899.50 thousand (+6.03%) on September 1, 2024.
- Over the past year, APDN TTM EBIT has increased by +$411.90 thousand (+2.85%).
- APDN TTM EBIT is now -319.93% below its all-time high of $6.38 million, reached on December 31, 2009.
Performance
APDN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
APDN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.0% | +9.6% | +2.9% |
| 3 y3 years | -12.0% | -21.0% | -27.1% |
| 5 y5 years | -65.9% | -21.0% | -27.1% |
APDN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.0% | at low | -168.4% | +30.5% | -33.8% | +6.0% |
| 5 y | 5-year | -65.9% | at low | -168.4% | +30.5% | -78.3% | +6.0% |
| alltime | all time | -373.5% | +72.9% | -131.9% | +88.8% | -319.9% | +73.6% |
Applied DNA Sciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$14.02 M(+28.0%) | - | - |
| Sep 2024 | - | -$3.27 M(-2.3%) | -$14.02 M(-6.0%) |
| Jun 2024 | - | -$3.35 M(-7.5%) | -$14.92 M(+3.4%) |
| Mar 2024 | - | -$3.62 M(-4.5%) | -$14.44 M(+6.8%) |
| Dec 2023 | - | -$3.79 M(-9.2%) | -$13.52 M(+23.5%) |
| Sep 2023 | -$10.95 M(-21.6%) | -$4.17 M(+45.9%) | -$10.95 M(-0.7%) |
| Jun 2023 | - | -$2.86 M(+5.7%) | -$11.03 M(+0.0%) |
| Mar 2023 | - | -$2.70 M(+121.8%) | -$11.03 M(+5.2%) |
| Dec 2022 | - | -$1.22 M(-71.3%) | -$10.48 M(-25.0%) |
| Sep 2022 | -$13.97 M(+11.5%) | -$4.25 M(+48.9%) | -$13.97 M(+3.9%) |
| Jun 2022 | - | -$2.86 M(+32.6%) | -$13.45 M(-4.2%) |
| Mar 2022 | - | -$2.15 M(-54.2%) | -$14.03 M(-1.1%) |
| Dec 2021 | - | -$4.71 M(+26.1%) | -$14.20 M(+13.9%) |
| Sep 2021 | -$12.53 M(-0.1%) | -$3.73 M(+8.4%) | -$12.46 M(-2.5%) |
| Jun 2021 | - | -$3.44 M(+48.6%) | -$12.78 M(+2.0%) |
| Mar 2021 | - | -$2.32 M(-22.1%) | -$12.53 M(-2.8%) |
| Dec 2020 | - | -$2.97 M(-26.6%) | -$12.90 M(+2.9%) |
| Sep 2020 | -$12.54 M(+48.3%) | -$4.05 M(+27.1%) | -$12.54 M(+30.0%) |
| Jun 2020 | - | -$3.19 M(+18.9%) | -$9.65 M(+22.2%) |
| Mar 2020 | - | -$2.68 M(+2.7%) | -$7.90 M(+0.4%) |
| Dec 2019 | - | -$2.61 M(+124.5%) | -$7.86 M(-6.9%) |
| Sep 2019 | -$8.46 M(-27.4%) | -$1.16 M(-19.2%) | -$8.45 M(-21.4%) |
| Jun 2019 | - | -$1.44 M(-45.7%) | -$10.75 M(-11.7%) |
| Mar 2019 | - | -$2.65 M(-17.1%) | -$12.18 M(+4.4%) |
| Dec 2018 | - | -$3.20 M(-7.8%) | -$11.67 M(+0.2%) |
| Sep 2018 | -$11.65 M(-9.2%) | -$3.47 M(+20.9%) | -$11.65 M(+5.6%) |
| Jun 2018 | - | -$2.87 M(+34.0%) | -$11.02 M(+2.5%) |
| Mar 2018 | - | -$2.14 M(-32.6%) | -$10.76 M(-10.6%) |
| Dec 2017 | - | -$3.17 M(+11.7%) | -$12.04 M(-6.1%) |
| Sep 2017 | -$12.82 M(+5.1%) | -$2.84 M(+9.2%) | -$12.82 M(+3.5%) |
| Jun 2017 | - | -$2.60 M(-23.9%) | -$12.39 M(-6.2%) |
| Mar 2017 | - | -$3.42 M(-13.4%) | -$13.21 M(-0.2%) |
| Dec 2016 | - | -$3.95 M(+64.1%) | -$13.23 M(+8.5%) |
| Sep 2016 | -$12.20 M(+55.3%) | -$2.41 M(-29.6%) | -$12.20 M(+18.7%) |
| Jun 2016 | - | -$3.42 M(-0.7%) | -$10.28 M(+20.5%) |
| Mar 2016 | - | -$3.45 M(+18.0%) | -$8.53 M(+22.5%) |
| Dec 2015 | - | -$2.92 M(+498.6%) | -$6.96 M(-11.4%) |
| Sep 2015 | -$7.85 M(-36.0%) | -$487.90 K(-70.8%) | -$7.86 M(-23.1%) |
| Jun 2015 | - | -$1.67 M(-11.0%) | -$10.21 M(-7.4%) |
| Mar 2015 | - | -$1.88 M(-50.8%) | -$11.03 M(-10.2%) |
| Dec 2014 | - | -$3.82 M(+34.3%) | -$12.27 M(+0.0%) |
| Sep 2014 | -$12.27 M(+20.6%) | -$2.84 M(+14.3%) | -$12.27 M(+4.2%) |
| Jun 2014 | - | -$2.49 M(-20.5%) | -$11.78 M(-2.9%) |
| Mar 2014 | - | -$3.13 M(-18.0%) | -$12.14 M(+4.5%) |
| Dec 2013 | - | -$3.81 M(+62.1%) | -$11.62 M(+14.2%) |
| Sep 2013 | -$10.18 M(+56.4%) | -$2.35 M(-17.3%) | -$10.18 M(+6.1%) |
| Jun 2013 | - | -$2.84 M(+9.0%) | -$9.59 M(+17.3%) |
| Mar 2013 | - | -$2.61 M(+9.9%) | -$8.17 M(+15.7%) |
| Dec 2012 | - | -$2.37 M(+34.3%) | -$7.07 M(+8.6%) |
| Sep 2012 | -$6.51 M | -$1.77 M(+23.8%) | -$6.51 M(-23.6%) |
| Jun 2012 | - | -$1.43 M(-4.9%) | -$8.52 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$1.50 M(-17.2%) | -$8.58 M(-1.9%) |
| Dec 2011 | - | -$1.81 M(-52.0%) | -$8.74 M(+8.5%) |
| Sep 2011 | -$8.06 M(+13.2%) | -$3.78 M(+153.3%) | -$8.06 M(+31.2%) |
| Jun 2011 | - | -$1.49 M(-10.4%) | -$6.14 M(-13.8%) |
| Mar 2011 | - | -$1.66 M(+47.9%) | -$7.12 M(+6.9%) |
| Dec 2010 | - | -$1.12 M(-39.5%) | -$6.66 M(-6.4%) |
| Sep 2010 | -$7.12 M(-238.8%) | -$1.86 M(-24.7%) | -$7.12 M(+10.3%) |
| Jun 2010 | - | -$2.47 M(+105.4%) | -$6.45 M(+27.1%) |
| Mar 2010 | - | -$1.20 M(-24.0%) | -$5.08 M(-179.6%) |
| Dec 2009 | - | -$1.58 M(+32.6%) | $6.38 M(+24.4%) |
| Sep 2009 | $5.13 M(-223.4%) | -$1.19 M(+8.9%) | $5.13 M(-6.9%) |
| Jun 2009 | - | -$1.10 M(-110.7%) | $5.51 M(-3.8%) |
| Mar 2009 | - | $10.25 M(-461.8%) | $5.73 M(-209.2%) |
| Dec 2008 | - | -$2.83 M(+248.8%) | -$5.24 M(+26.1%) |
| Sep 2008 | -$4.16 M(-66.9%) | -$812.20 K(-7.6%) | -$4.16 M(-56.0%) |
| Jun 2008 | - | -$879.00 K(+22.5%) | -$9.45 M(-11.5%) |
| Mar 2008 | - | -$717.30 K(-58.9%) | -$10.68 M(-11.7%) |
| Dec 2007 | - | -$1.75 M(-71.4%) | -$12.10 M(-3.5%) |
| Sep 2007 | -$12.54 M(-20.1%) | -$6.11 M(+190.6%) | -$12.54 M(-24.7%) |
| Jun 2007 | - | -$2.10 M(-1.6%) | -$16.65 M(+1.1%) |
| Mar 2007 | - | -$2.14 M(-2.5%) | -$16.46 M(+4.9%) |
| Dec 2006 | - | -$2.19 M(-78.6%) | -$15.69 M(-0.1%) |
| Sep 2006 | -$15.71 M(-69.6%) | -$10.22 M(+433.9%) | -$15.71 M(-54.7%) |
| Jun 2006 | - | -$1.91 M(+40.1%) | -$34.64 M(-2.5%) |
| Mar 2006 | - | -$1.37 M(-38.0%) | -$35.53 M(-20.3%) |
| Dec 2005 | - | -$2.20 M(-92.4%) | -$44.58 M(-16.2%) |
| Sep 2005 | -$51.71 M(+194.1%) | -$29.16 M(+938.8%) | -$53.17 M(+73.7%) |
| Jun 2005 | - | -$2.81 M(-73.0%) | -$30.61 M(+3.8%) |
| Mar 2005 | - | -$10.41 M(-3.6%) | -$29.48 M(+40.5%) |
| Dec 2004 | - | -$10.80 M(+63.8%) | -$20.97 M(+19.3%) |
| Sep 2004 | -$17.58 M(+407.0%) | -$6.59 M(+294.1%) | -$17.58 M(+14.3%) |
| Jun 2004 | - | -$1.67 M(-12.4%) | -$15.38 M(+9.6%) |
| Mar 2004 | - | -$1.91 M(-74.2%) | -$14.03 M(+11.8%) |
| Dec 2003 | - | -$7.41 M(+68.7%) | -$12.56 M(+137.1%) |
| Sep 2003 | -$3.47 M(>+9900.0%) | -$4.39 M(+1247.4%) | -$5.30 M(+484.6%) |
| Jun 2003 | - | -$325.90 K(-24.7%) | -$906.10 K(+56.2%) |
| Mar 2003 | - | -$433.00 K(+194.2%) | -$580.20 K(+294.2%) |
| Dec 2002 | - | -$147.20 K(>+9900.0%) | -$147.20 K(+1611.6%) |
| Dec 2001 | -$8600.00(+1128.6%) | -$200.00(-97.6%) | -$8600.00(0.0%) |
| Sep 2001 | - | -$8200.00(+8100.0%) | -$8600.00(+1333.3%) |
| Jun 2001 | - | -$100.00(0.0%) | -$600.00(-14.3%) |
| Mar 2001 | - | -$100.00(-50.0%) | -$700.00(-12.5%) |
| Dec 2000 | -$700.00(-79.4%) | -$200.00(0.0%) | -$800.00(-77.8%) |
| Sep 2000 | - | -$200.00(0.0%) | -$3600.00(+5.9%) |
| Jun 2000 | - | -$200.00(0.0%) | -$3400.00(0.0%) |
| Mar 2000 | - | -$200.00(-93.3%) | -$3400.00(0.0%) |
| Dec 1999 | -$3400.00(+112.5%) | -$3000.00(<-9900.0%) | -$3400.00(+750.0%) |
| Sep 1999 | - | $0.00(-100.0%) | -$400.00(0.0%) |
| Jun 1999 | - | -$200.00(0.0%) | -$400.00(+100.0%) |
| Mar 1999 | - | -$200.00 | -$200.00 |
| Dec 1998 | -$1600.00(+166.7%) | - | - |
| Dec 1997 | -$600.00 | - | - |
FAQ
- What is Applied DNA Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Applied DNA Sciences?
- What is Applied DNA Sciences annual EBIT year-on-year change?
- What is Applied DNA Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Applied DNA Sciences?
- What is Applied DNA Sciences quarterly EBIT year-on-year change?
- What is Applied DNA Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Applied DNA Sciences?
- What is Applied DNA Sciences TTM EBIT year-on-year change?
What is Applied DNA Sciences annual earnings before interest & taxes?
The current annual EBIT of APDN is -$14.02 M
What is the all time high annual EBIT for Applied DNA Sciences?
Applied DNA Sciences all-time high annual earnings before interest & taxes is $5.13 M
What is Applied DNA Sciences annual EBIT year-on-year change?
Over the past year, APDN annual earnings before interest & taxes has changed by -$3.07 M (-28.04%)
What is Applied DNA Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of APDN is -$3.27 M
What is the all time high quarterly EBIT for Applied DNA Sciences?
Applied DNA Sciences all-time high quarterly earnings before interest & taxes is $10.25 M
What is Applied DNA Sciences quarterly EBIT year-on-year change?
Over the past year, APDN quarterly earnings before interest & taxes has changed by +$346.50 K (+9.58%)
What is Applied DNA Sciences TTM earnings before interest & taxes?
The current TTM EBIT of APDN is -$14.02 M
What is the all time high TTM EBIT for Applied DNA Sciences?
Applied DNA Sciences all-time high TTM earnings before interest & taxes is $6.38 M
What is Applied DNA Sciences TTM EBIT year-on-year change?
Over the past year, APDN TTM earnings before interest & taxes has changed by +$411.90 K (+2.85%)